Hannah Dellabella

New guidelines from the International Headache Society aim to affect the design, conduct, and reporting for clinical trials in migraine.

Rapid eye movement sleep behavior disorder features may be a clinical marker for faster cognitive decline in Parkinson disease.

Lipid-lowering was associated with an increased risk for stroke in secondary prevention trials alone.

Women vs men with tension-type headache may have a higher number of trigger points and lower pressure pain thresholds.

For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.

Inhibition of trigeminal nociception may be impaired in individuals with migraine.

The American Heart Association has updated its scientific statement on blood pressure readings.

In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.

These results suggest that CHA2DS2-VASc scores should be continually reassessed, perhaps annually, in patients with atrial fibrillation.

Approximately half of patients with migraine have kinesiophobia, and the condition is associated with greater severity, not presence of cutaneous allodynia.

Investigators examine the long-term outcomes of pallidal deep brain stimulation in x-linked dystonia-parkinsonism.

In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.

The European Headache Federation has issued recommendations on how to best diagnose and treat idiopathic intracranial hypertension.

The novel questionnaire may identify patients with ALS suffering from dyspnea and allow early assessment and monitoring for symptom management.

Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.

Investigators examined the involvement of depression and anxiety on cognition and falls in patients with multiple sclerosis.

Investigators sought to determine whether subthalamic nucleus deep brain stimulation could influence clinical outcomes in patients with Parkinson disease.

A cerebrospinal fluid Aβ level may be a predictive biomarker for multiple sclerosis progression.

The Apathy Evaluation Scale was shorted to two-thirds of the original length and investigators evaluated the validity in Parkinson disease.

Investigators examine identifiers to predict disability in patients with relapsing-onset multiple sclerosis.

This study compared driving performance measures from on-the-road, driving simulator, and real-life crash studies in patients with Parkinson disease.

The PBMSI comprises 5 items that patients identified to be the most important to their quality of life: mood, concentration, fatigue, and roles and responsibilities.

Patients with Parkinson’s showed evidence of retaining previously-learned spatial preference.

The location of migraine pain may not be associated with psychiatric distress, emergency department visits, or healthcare use.

Following the close of the 2018 World Cup, FIFA must consider how to better handle concussions moving forward.

Investigators sought to determine whether brain volume loss of less than 0.4% serves as a marker of therapeutic response in patients with multiple sclerosis.

Investigators seek insight into the mechanisms of sphenopalatine ganglion blockade by repetitive parasympathetic inhibition.

Lower average lifetime exposure to low levels of ultraviolet radiation may increase the risk for MS development in adults living in the United States.

Participants with episodic migraine had significantly lower vision-specific quality of life compared with healthy control patients.

Investigators examine whether 3T MRI imaging would improve detection in patients presenting with clinically isolated syndrome to fulfil MS diagnostic criteria.